Skip to main content
Veterinary Medicines

Streptocillin vet. injeksjonsvæske, suspensjon

Authorised
  • Dihydrostreptomycin
  • Benzylpenicillin procaine

Product identification

Medicine name:
Streptocillin vet. injeksjonsvæske, suspensjon
Active substance:
  • Dihydrostreptomycin
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Pig
  • Sheep
  • Goat
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Intrauterine use
  • Intraperitoneal use
  • Intrasynovial use

Product details

Active substance and strength:
  • Dihydrostreptomycin
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat
        60
        day
      • Milk
        3
        day
    • Pig
      • Meat
        60
        day
    • Sheep
      • Meat
        60
        day
      • Milk
        3
        day
    • Goat
      • Meat
        60
        day
      • Milk
        3
        day
    • Horse
      • Meat
        60
        day
  • Subcutaneous use
    • Cattle
      • Meat
        60
        day
      • Milk
        3
        day
    • Pig
      • Meat
        60
        day
    • Sheep
      • Meat
        60
        day
      • Milk
        3
        day
    • Goat
      • Meat
        60
        day
      • Milk
        3
        day
    • Horse
      • Meat
        60
        day
  • Intrauterine use
    • Cattle
      • Meat
        6
        day
      • Milk
        3
        day
    • Pig
      • Meat
        6
        day
    • Sheep
      • Meat
        6
        day
      • Milk
        3
        day
    • Goat
      • Meat
        6
        day
      • Milk
        3
        day
    • Horse
      • Meat
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Denmark A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 3600
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 28/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 28/01/2025